• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

’Quilting Sutures’ for the Prevention of Hysterectomy in Women with Postpartum Hemorrhage

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • ‘Quilting sutures’, a backstitch quilting technique, was first performed in 2007 and reported in 2012
  • Stein et al. (International Journal of Obstetrics & Gynaecology, 2018) determined whether “quilting” sutures are safe and effective for preventing hysterectomy among women with postpartum hemorrhage (PPH)

METHODS:

  • Retrospective study
  • The authors describe suture technique as follows (see YouTube Video in ‘Primary Sources – Learn More’ section, below)

Starting at the top of the uterus continuing down to the cervical segment, horizontally placed U-sutures were used to fix the anterior to the posterior wall. Up to 12 size 1 absorbable sutures (Vicryl) were applied to compress the uterus completely.

  • Sutures placed in women with PPH following cesarean section and administration of uterotonics
  • Objective and subjective data were collected by analyzing medical records and performing telephone interviews (2007 to 2016)
  • Trends were also analyzed by comparing
    • Women in the first 50%
    • Women in the second 50% (use of quilting sutures were more common and used immediately after failure of medical treatment, prior to massive blood loss)

RESULTS:

  • 26 cesarean sections using quilting sutures were performed more frequently over time
    • 8 sutures performed during 2007-2011 (first 5-year period)
    • 18 sutures performed during 2012–2106 (second 5-year period)
    • Characteristics, overall, between the first 13 women were similar to the second cohort of 13 women
      • First group had more inductions (7 vs 2)
    • More women in the first 50% group had manual compression, indicating use of other techniques prior to quilting sutures compared to the latter 50%
  • Comparing the first 50% of women to the 2nd 50%
    • Intensive care: Was more frequent in the first 13 procedures (10 women) vs second 13 procedures (5 women)
    • Blood transfusion: Was more frequent in the first 13 procedures (9 women) vs second 13 procedures (4 women)
  • Three women who desired to have a child subsequently delivered a newborn
  • Menses restarted by 7 weeks postpartum (for women not on hormonal contraceptives)
    • One women reported amenorrhea
  • 2 hysterectomies
    • Therapeutic anticoagulation following pulmonary embolism
    • Quilting suture failure: PPH could not be controlled

CONCLUSION:

  • Authors acknowledge small sample size and lack of prospective data
  • Quilting sutures were a safe and efficient prevention of hysterectomies in PPH
  • Less tissue is compressed compared to other techniques such as B-Lynch
  • The authors state

…horizontal application of U-stiches, which facilitates optimal oxygenation from both arteriae uterinae

Learn More – Primary Sources:

Effect of early “quilting” sutures on morbidity in postpartum hemorrhage

Video: Quilting Suture Technique for PPH

“Quilting” sutures to prevent hysterectomy in patients with postpartum hemorrhage

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone

Learn More »

image_pdfFavoriteLoadingFavorite

< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Postpartum Hemorrhage – Medications to Treat Uterine Atony 
How Effective is Intrauterine Balloon Tamponade for Severe Postpartum Hemorrhage
Heat Stable Carbetocin: A Heat-Stable Alternative to Oxytocin?
Latest Cochrane Review: What is the Most Effective Prophylactic Treatment for Postpartum Hemorrhage?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site